Skip to content
★ Sign in to follow
汪

汪建

Directeur
华大基因
Total declarations
4
Companies
2
▲ Purchases (2 ops.)
€2.1M
▼ Sales (0 ops.)
—

Latest filing published 28 Jan 2022 for 华大基因, €875k.

Filing timeline

BuySale
汪建

Insider track record

Disclosed buys
2
Disclosed sells
0
Signal history

Closed purchases

Market purchases
2
Positive at T+90
0%
Median T+90
-16.1%

Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 28 Jan 2022 · 1745 days ago · €875k
    -36.4%
    Entry CN¥86.29 · Close at T+365 CN¥54.85
  • Filed 21 Dec 2021 · 1783 days ago · €1.2M
    -41.1%
    Entry CN¥88.78 · Close at T+365 CN¥52.25

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

汪建: trading record in brief

汪建, listed as senior executive, has filed trades across 2 companies (mainly through SSE / SZSE (CSRC)), most often in Yee Hop Holdings Ltd. and 华大基因. The record holds 4 filings, for trades running from 19 April 2021 to 31 May 2023.

Purchases make up the whole of the open-market record (2 purchases, €2.1M). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.

The newest entry dates from 31 May 2023: a transaction, in Yee Hop Holdings Ltd. The latest purchase dates back some time: it was published 1,745 days ago, on 28 January 2022. Half of the filings or more reach the SSE / SZSE (CSRC) feed on the day of the trade. This delay matters because a trade only becomes useful information once it is public. Source: insider filings from SSE / SZSE (CSRC). Past trades are no guide to future returns.

Companies and markets linked to 汪建

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations2 total
  • ▲
    董事Executives华大基因
    6M CNY11SZSE
    74,000 shares42.2% of flowA股XSHESZSE:173000005350203740
    Canonical exit: 28 Apr 2022 (T+90)
  • ▲
    董事Executives华大基因
    9M CNY13SZSE
    105,500 shares57.8% of flowA股XSHESZSE:173000005186031170
    Canonical exit: 21 Mar 2022 (T+90)

2 of 2 declarations